Sat, Feb 28, 2015, 8:10 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

ONYX Pharmaceuticals, Inc. Message Board

  • llabtechtwo llabtechtwo Sep 22, 2012 12:20 PM Flag

    Kyprolis REV???

    We have had a pretty decent run on no news.... My two thoughts are someone in the "know" believes a buyout is imminent or someone thinks onxx will surprise to the upside on next earnings. I personally don't think the latter will materialize, so that leaves me thinking a buyout is in the works!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • We have indication of potential good sales from kyprolis. And impending regorafenib approval by end of Oct. With present nexavar and good kyprolis sales alone, 90$ target is reasonable. With regorafenib approval news pending by end of Oct and 5 phase 3 trials due to report results by end of year, there is high chance additional good news results...and finally we have potential buyout...the risk/reward for hedge funds, other institutional favors buying...I am now looking for 100+ before end of year.

      Sentiment: Strong Buy

124.700.0000(0.00%)Sep 30 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Herbalife Ltd.
NYSEFri, Feb 27, 2015 4:01 PM EST